Sale!

PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PLEC Gene Epidermolysis Bullosa Simplex with Muscular Dystrophy Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the PLEC gene. These mutations are known to cause Epidermolysis Bullosa Simplex with Muscular Dystrophy (EBS-MD), a rare genetic disorder that affects the skin and muscles, leading to symptoms such as blistering of the skin and progressive muscle weakness. The test is crucial for early diagnosis, enabling targeted interventions and management strategies to improve the quality of life for affected individuals. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise involved in conducting this advanced genetic analysis. This test represents a significant step forward in the personalized medicine approach, offering hope to families affected by this challenging condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy Genetic Test

At DNA Labs UAE, we offer the PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy Genetic Test. This test is designed to detect mutations in the PLEC gene, which is associated with a rare genetic disorder called Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD).

Test Components and Price

The cost of the PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy Genetic Test is AED 4400.0. The test can be performed using blood or extracted DNA, or even just one drop of blood on an FTA card.

Report Delivery and Method

The report for the PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy Genetic Test will be delivered within 3 to 4 weeks. The test utilizes NGS (Next Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes.

Test Type and Doctor

The PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy Genetic Test falls under the category of Neurological Disorders. The test is conducted by a Neurologist in our Test Department of Genetics.

Pre Test Information

Prior to undergoing the PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy Genetic Test, it is recommended to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with EBS-MD.

Test Details

Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) is a rare genetic disorder characterized by blistering skin and muscle weakness. The PLEC gene is associated with this disorder. NGS genetic testing is a powerful tool used to detect mutations in the PLEC gene. This type of testing allows for the analysis of multiple genes simultaneously, increasing the chances of identifying disease-causing mutations.

Sample Types and Results

NGS genetic testing for EBS-MD can be performed using various sample types, including blood, saliva, and tissue samples. The results of this testing can confirm a diagnosis of EBS-MD, aid in treatment decisions, and provide information about the risk of passing the disorder on to future generations.

Test Name PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PLEC Gene Epidermolysis bullosa simplex with muscular dystrophy
Test Details

The PLEC gene is associated with a rare genetic disorder called Epidermolysis bullosa simplex with muscular dystrophy (EBS-MD). This disorder is characterized by the presence of blistering skin and muscle weakness.

NGS (Next Generation Sequencing) genetic testing is a powerful tool that can be used to detect mutations in the PLEC gene. This type of testing allows for the simultaneous analysis of multiple genes, which can increase the likelihood of identifying disease-causing mutations.

NGS genetic testing for EBS-MD can be performed using a variety of sample types, including blood, saliva, and tissue samples. The results of this testing can be used to confirm a diagnosis of EBS-MD, as well as to inform treatment decisions and provide information about the risk of passing the disorder on to future generations.